- Home
- ALLK
ALLK
Allakos Inc.
as 11-15-2024 4:00pm EST
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | SAN CARLOS |
| Market Cap: | 58.0M | IPO Year: | 2018 |
| Target Price: | $1.67 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.54 - $3.41 | Next Earning Date: | 11-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Allakos Inc. News
ALLK Breaking Stock News: Dive into ALLK Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy
GlobeNewswire
11 days ago
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results
Simply Wall St.
a month ago
3 US Penny Stocks With Market Caps Larger Than $50M
MT Newswires
a month ago
Allakos Subcutaneous Therapy for Mast Cells-Related Diseases 'Well-Tolerated;' Shares Up After Hours
GlobeNewswire
a month ago
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
MT Newswires
3 months ago
Allakos Gets Nasdaq Noncompliance Notice on Minimum Bid Price
GlobeNewswire
3 months ago
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Simply Wall St.
4 months ago
Can Allakos (NASDAQ:ALLK) Afford To Invest In Growth?
Compare ALLK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALLK Allakos Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.